Thompson Davis & Co., Inc. Eli Lilly & CO Transaction History

Thompson Davis & Co., Inc.

$132 Million
Q3 2024

A detailed history of Thompson Davis & Co., Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Thompson Davis & Co., Inc. holds 1,537 shares of LLY stock, worth $1.18 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

1,537

Previous 1,687 8.89%

Holding current value

$1.18 Million

Previous $1.53 Million 10.87%

% of portfolio

1.03%

Previous 1.36%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$772.14 - $960.02 $115,821 - $144,003	-150 Reduced 8.89%	1,537 $1.36 Million
Q2 2024 Jul 23, 2024	BUY	$724.87 - $909.04 $8,698 - $10,908	12 Added 0.72%	1,687 $1.53 Million
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $23,688 - $31,691	-40 Reduced 2.33%	1,675 $1.3 Million
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $451,663 - $532,451	-860 Reduced 33.4%	1,715 $999,000
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $554,242 - $764,107	-1,275 Reduced 33.12%	2,575 $1.38 Million
Q2 2023 Jul 13, 2023	BUY	$350.74 - $468.98 $17,537 - $23,449	50 Added 1.32%	3,850 $1.81 Million
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $15,531 - $18,241	50 Added 1.33%	3,800 $1.3 Million
Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $16,077 - $18,733	50 Added 1.35%	3,750 $1.37 Million
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $177,888 - $202,722	600 Added 19.35%	3,700 $1.2 Million
Q2 2022 Aug 04, 2022	SELL	$278.73 - $327.27 $55,746 - $65,454	-200 Reduced 6.06%	3,100 $1.01 Million
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $367,923 - $431,996	1,320 Added 66.67%	3,300 $1.07 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $464,686 - $577,486	1,980 New	1,980 $567,000
Q1 2018 May 02, 2018	SELL	$74.21 - $87.6 $7,420 - $8,760	-100 Closed	0 $0
Q4 2017 Feb 05, 2018	SELL	$81.94 - $87.89 $51,458 - $55,194	-628 Reduced 86.26%	100 $8,000
Q3 2017 Oct 30, 2017	BUY	$77.07 - $85.54 $4,470 - $4,961	58 Added 8.66%	728 $62,000
Q2 2017 Aug 10, 2017	BUY	N/A	670	670 $55,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Davis & Co., Inc. with notifications on news.

Account

Thompson Davis & Co., Inc. Eli Lilly & CO Transaction History